Testosterone and type 2 diabetes

Clicks: 287
ID: 266232
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 5 articles by views in current opinion in endocrinology, diabetes, and obesity

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Low testosterone levels are very commonly found in men with T2D and are associated with aging and obesity. Whether testosterone treatment in men with T2D decreases insulin resistance above that attributable to its fat-reducing effect is currently unknown. Future studies should compare testosterone t …
Reference Key
m2010currenttestosterone Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Grossmann M;Gianatti EJ;Zajac JD;;
Journal current opinion in endocrinology, diabetes, and obesity
Year 2010
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20418720
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't male diabetes mellitus type 2 / physiopathology* insulin resistance / physiology testosterone / physiology* pmid:20418720 doi:10.1097/med.0b013e32833919cf mathis grossmann emily j gianatti jeffrey d zajac adiposity / physiology aging / physiology metabolic syndrome / physiopathology sex hormone-binding globulin / physiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.